Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study - Full Text View

This study is currently recruiting participants.

Verified by University of California, Davis, February 2008

First Received: February 4, 2008 Last Updated: February 14, 2008 History of Changes

Sponsors and Collaborators:	University of California, Davis The Slovenian Ministry of Higher Education, Science and Technology
Information provided by:	University of California, Davis
ClinicalTrials.gov Identifier:	NCT00616317

Purpose

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Condition
Antiphospholipid Syndrome

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Further study details as provided by University of California, Davis:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	50
Study Start Date:	September 2006
Estimated Study Completion Date:	January 2010
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)

Eligibility

Study Population

Pediatric Nephrology Clinic at University of California, Davis

Criteria

Inclusion Criteria:

18 years of age or younger at the onset of disease
Presence of Vascular Thrombosis
UC Davis patient
Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00616317

Contacts

Contact: J. Gularte

(916) 734-7222

Locations

United States, California
UC Davis Medical Center	Recruiting
Sacramento, California, United States, 95817

Sponsors and Collaborators

University of California, Davis

The Slovenian Ministry of Higher Education, Science and Technology

Investigators

Principal Investigator:

Lavjay Butani, M.D.

University of California, Davis

More Information

Additional Information:

Related Info This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	University of California, Davis Medical Center ( Lavjay Butani,M.D./ Associate Professor & Section Chief of Pediatric Nephrology )
Study ID Numbers:	200614666-1
Study First Received:	February 4, 2008
Last Updated:	February 14, 2008
ClinicalTrials.gov Identifier:	NCT00616317 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of California, Davis:

Antiphospholipid Syndrome

Study placed in the following topic categories:

Autoimmune Diseases
Antiphospholipid Syndrome

Additional relevant MeSH terms:

Autoimmune Diseases
Pathologic Processes
Disease

Immune System Diseases
Syndrome
Antiphospholipid Syndrome

ClinicalTrials.gov processed this record on September 10, 2009